These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18926432)

  • 1. Advances in MR spectroscopy of the prostate.
    Kurhanewicz J; Vigneron DB
    Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):697-710, ix-x. PubMed ID: 18926432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo MR spectroscopic imaging of the prostate, from application to interpretation.
    Tayari N; Heerschap A; Scheenen TWJ; Kobus T
    Anal Biochem; 2017 Jul; 529():158-170. PubMed ID: 28167072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.
    Shukla-Dave A; Hricak H; Akin O; Yu C; Zakian KL; Udo K; Scardino PT; Eastham J; Kattan MW
    BJU Int; 2012 May; 109(9):1315-22. PubMed ID: 21933336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MR spectroscopic imaging for evaluation of prostate cancer].
    Taouli B
    J Radiol; 2006 Feb; 87(2 Pt 2):222-7. PubMed ID: 16484947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR spectroscopic imaging: principles and recent advances.
    Posse S; Otazo R; Dager SR; Alger J
    J Magn Reson Imaging; 2013 Jun; 37(6):1301-25. PubMed ID: 23188775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
    Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
    Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.
    Hricak H
    Br J Radiol; 2005; 78 Spec No 2():S103-11. PubMed ID: 16306632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging and spectroscopic imaging of prostate cancer.
    Coakley FV; Qayyum A; Kurhanewicz J
    J Urol; 2003 Dec; 170(6 Pt 2):S69-75; discussion S75-6. PubMed ID: 14610414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe.
    Arteaga de Castro CS; Boer VO; Luttje MP; van der Velden TA; Bhogal A; van Vulpen M; Luijten PR; van der Heide UA; Klomp DW
    NMR Biomed; 2014 Nov; 27(11):1353-60. PubMed ID: 25212868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectroscopy in prostate cancer: hope or hype?
    Roach M; Kurhanewicz J; Carroll P
    Oncology (Williston Park); 2001 Nov; 15(11):1399-410; discussion 1415-6, 1418. PubMed ID: 11758871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer.
    Nayyar R; Kumar R; Kumar V; Jagannathan NR; Gupta NP; Hemal AK
    BJU Int; 2009 Jun; 103(12):1614-20. PubMed ID: 19338548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging and MR spectroscopic imaging of prostate cancer.
    Rajesh A; Coakley FV
    Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):557-79, vii. PubMed ID: 15271371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer.
    Westphalen AC; McKenna DA; Kurhanewicz J; Coakley FV
    J Endourol; 2008 Apr; 22(4):789-94. PubMed ID: 18366322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.
    Shukla-Dave A; Hricak H; Ishill N; Moskowitz CS; Drobnjak M; Reuter VE; Zakian KL; Scardino PT; Cordon-Cardo C
    Clin Cancer Res; 2009 Jun; 15(11):3842-9. PubMed ID: 19435838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
    Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
    Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.
    Wang L; Hricak H; Kattan MW; Chen HN; Scardino PT; Kuroiwa K
    Radiology; 2006 Feb; 238(2):597-603. PubMed ID: 16344335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of the prostate in clinical practice.
    Mazaheri Y; Shukla-Dave A; Muellner A; Hricak H
    MAGMA; 2008 Nov; 21(6):379-92. PubMed ID: 18795354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
    Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR
    Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in proton MR spectroscopic imaging of prostate cancer.
    Stamatelatou A; Scheenen TWJ; Heerschap A
    MAGMA; 2022 Aug; 35(4):645-665. PubMed ID: 35445307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging.
    Casciani E; Gualdi GF
    Abdom Imaging; 2006; 31(4):490-9. PubMed ID: 16955379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.